Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a98:c004:0:b0:1eb:e128:bbe3 with SMTP id l4csp2529892eic;
        Fri, 12 Jan 2024 16:34:16 -0800 (PST)
X-Google-Smtp-Source: AGHT+IEyxkBK5s2wno2SSkul7x1GJltW2querkx5uJvL+GyAYCY7fxVOO5Lw9Gq33ZDzERIaZoBk
X-Received: by 2002:a05:6808:1154:b0:3bd:4c35:343e with SMTP id u20-20020a056808115400b003bd4c35343emr2170224oiu.11.1705106056442;
        Fri, 12 Jan 2024 16:34:16 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1705106056; cv=none;
        d=google.com; s=arc-20160816;
        b=duwvHJDhBzXzsB9PrD/5Gbjl8BUjULcEglJskarEvKFYgxP/05qBKMTwCzgMqb5g5v
         3pT48rZNN85LmUOC5revYpDByVTEdfyUkaZd8THiv23jzVRgWIXkKr+qCGT2s7tp6mGG
         yBk/vrA6qVNb3GlrDSQAQjHr2N/F65hsicy1cBIJZFWdPJutUotb7TWQMiDR1Yy8jkLh
         E7UdZ1m+qphXqd9krAgC4ZtsABkn791hVqA+mutRp+R5NqZQsVdpsDyrZVGhtR2rX0u3
         eZSTeBZedDIFzT55L2qTRI/sAt7PP2LsOA5kF+KtLi8nqHcpoEH/zhhnOMeKQt3zMftL
         RvlA==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=1iFlq0AZbpYQj0yQVlHNcwEKEDkYQ8I15fHqlqkRQ30=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=Wm16RksrTdh5WE6Od/HsLp2yJlcmGCCvK5Gc6y5g6wbCrVEBAfoXi1t8wezB74lIm7
         HiXVieTXJEmzHNak40UnhuQ5LErbs1zoUb2wh1LVGYA4nMz69zyl+Qtfuuq9xmCtx2zn
         7tPA823USVXIMdP5jsHapezCSYuZg+Z3eSevcvMkutdA7Ho79K4szwTp2xxRcIHlUd7I
         YMN2TaXdsrk1RKdNLXC265ewCaBONk+kFEEX9SHEslOJfGln+7M54PwC98lqvmUyJ/rs
         6tnFBTSiiaSmFFdcQ9eQWClDX9OT4gU8mYHgbkagiQIzAIBtYLKqixVC6h0IppcPXikU
         bhtw==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=Wm9SiNSM;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=EP6XJEJY;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id ld10-20020a056a004f8a00b006d9b2e96da3si4401034pfb.86.2024.01.12.16.34.15
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Fri, 12 Jan 2024 16:34:16 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=Wm9SiNSM;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=EP6XJEJY;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=1iFlq0AZbpYQj0yQVlHNcwEKEDkYQ8I15fHqlqkRQ30=;
	b=Wm9SiNSMJM23jp5lHCP4p7dQTueOM03y5a0NNXjTQsfV6VuXjJLV5nO3sp8uybWezrO/
	5yKhDPQ7TlUDotl39Bks3SWbx2BzuIDVk1JPNLMPw6nh4d/9+1vcJJjo8Qh2+UkE+1FIlA
	qp+5+LjKyK26lYKTfjtjLtgLUIkDsw2kw5Zfy/J8to3tecDVjLRGPGewf8kHhaCBnGJfQo
	BHrBokvEJc81UVmMdva3BijaNPWJLoBWhgrVsJ6my1X4Rb7gL4bymyHUipJZtqM8yF9cuH
	Kwp4ZIwRvxdvTnT77Lo0zCa+5BVcpCMN+PMndGCAMrE7BBYuADBkEWwcZx55niVw==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=1iFlq0AZbpYQj0yQVlHNcwEKEDkYQ8I15fHqlqkRQ30=;
	b=EP6XJEJYEkpv63Qug++RxX7+7iH+pe07xz0cp4zApR3aHC2dr/hLEnr3owW3TaXkDjjN
	3eq5OVOahyYKa8DRPLQFsJfiwCoebGiE8BJq6pK/iWrp3lo0Q1EBNh5vEUGJwfH/awmk4l
	Tgcmi++wRRrbHfNeXoXyUy6bIIrHs/pHI=
Received: by filterdrecv-5bccb9764b-lmwll with SMTP id filterdrecv-5bccb9764b-lmwll-1-65A1DA85-8
        2024-01-13 00:34:13.184166571 +0000 UTC m=+7537964.522107157
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-10 (SG) with HTTP
	id 0AlECQ_vQoeQUkEYiJ9SWw
	Sat, 13 Jan 2024 00:34:13.049 +0000 (UTC)
Content-Type: multipart/alternative; boundary=da95df9a243d6c650cddbbacc1be63885e2b4db53bad2a1b0c2f3db5f2e0
Date: Sat, 13 Jan 2024 00:34:14 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <0AlECQ_vQoeQUkEYiJ9SWw@geopod-ismtpd-10>
Subject: PRO/EDR> Measles - Israel: (north) nosocomial
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iBUjNblXO4zCioGglk6REzoU3J1AZD5sbsNQT7V?=
 =?us-ascii?Q?JQI7NbnoqfOXU18J+s2Hs5SOYUA7sXEmhdpnu7d?=
 =?us-ascii?Q?RnNGMB7u8wLnzCpFsFTZMTHKpQJLQq6C8wyU7s2?=
 =?us-ascii?Q?gounPXMjdYv6fznhe+q3rDOi2tQvJMdZ2EftX9n?=
 =?us-ascii?Q?mKhndzarciNb8fkH=2Fv=2FMTHvqYHMnISVC7UMTY8?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUhc93xcG=2F095a5S4+mt=2FG?=
 =?us-ascii?Q?uYUpctI=2FOGD2dwyi+uvm2j4FCdvuw0l9zcHM8iA?=
 =?us-ascii?Q?mojOvTXq7jOpDFFNtfsYkHQYACEW8pq1BXXqYmH?=
 =?us-ascii?Q?oGTsnt6QpE2ZV5WVqnpwfXWoLXx7+4Zmw706K=2Ff?=
 =?us-ascii?Q?0xn0z8XffP6wFG0GKTgIiBRCW3FAv+TtWQOrh2p?=
 =?us-ascii?Q?U5nuH0iAOrTuEIEp9uofQ27HyBefiOg5SBDFVSi?=
 =?us-ascii?Q?Dfk1gWhq2VNK6zZfw87QD1fv+6gwAV91ddtbpRg?=
 =?us-ascii?Q?VXqy8vzOlQ96qp56oJYur9o2u8i7+yfn4RvVXff?=
 =?us-ascii?Q?5IBvdJHjPvBWA3qgRyHHj+yE8z9oDcGXMU=2FPjAV?=
 =?us-ascii?Q?qSMpLV6JfwEBcsmBn6z4827w890IwD9hKHyxyev?=
 =?us-ascii?Q?VIe1G4eLo5VAB2NJ2+PXlciohkrdyMyiaHEYYn7?=
 =?us-ascii?Q?a=2FhLlYu5IMNMIydIhgpKAdySbgaESBCo2qLhzVF?=
 =?us-ascii?Q?wit+qjXW1bCW7eqxSksyRjn1hfzdgcei4EQ0yI5?=
 =?us-ascii?Q?xHCCJzpf7GxRP70Qoh+q0xFcGbb7YUwviaxEAo3?=
 =?us-ascii?Q?qXF5bSWcCH3tkM3l=2Fg4bBIbD5iAy=2FldlHEbr6CU?=
 =?us-ascii?Q?CRDgQDzsMc6G8FcLXK5SHeyikbwTZlsFqQFrSQp?=
 =?us-ascii?Q?4Epk1MIGNCS9JSmlE4G4fGIQT3yuUAK4SoKInbA?=
 =?us-ascii?Q?cRNSyId1mOzYigbaySgWMqZjcRLmSXMHpNhcH9J?=
 =?us-ascii?Q?xq7BUNu2B5aHnIdDLFmooiUmRRDbTot2dkC32Tk?=
 =?us-ascii?Q?3aWJK2KjaJN1uA+8VSSg6ectWQ=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2EkhwC3bRNk?=
 =?us-ascii?Q?pPos43kIUK=5FTGkhTwEvbAMBtB8Zfe7aGlRoMDAw?=
 =?us-ascii?Q?dTAwMLAnbpEufTf5LPxYjsKbx20PB28hcYP-7cL?=
 =?us-ascii?Q?3DOdxtTQjOoj1MqTpcycL3ZXH9nmPsw2oc8J6S4?=
 =?us-ascii?Q?gIIeO-cd0hBZVO2up3rTWcivsfYjZdhLcVx=5FlYj?=
 =?us-ascii?Q?DTpD3jPr1JxFybCeQ=3D=3D=2Evpj0l-6cYItYzsloosC?=
 =?us-ascii?Q?ZySy4v7SbMKCguOrJRpY2V95oMDAwdTAwMJ2Qk0?=
 =?us-ascii?Q?RZSay8EULZivSgghjPq5bY4sFMp5XG5X-keV-bc?=
 =?us-ascii?Q?6ZivnbWJ2nlfy5MFR8KMgmqbEv7zhsj2BbUWIFe?=
 =?us-ascii?Q?60JsDklaKBo-MLCd2XuziwWxfr4sdCEd174VDZU?=
 =?us-ascii?Q?g0=5Foh-PE-dBRX8U2e3=5FeYCMuijbHoCPErIWIJpg?=
 =?us-ascii?Q?ooxLdMwCDl21Ss0jMkXI2nb-drhfanaXcX9T3bQ?=
 =?us-ascii?Q?J5BdhQ66LdC0EJ5NVYPxMDKb2nZKNnyFhbgWyxy?=
 =?us-ascii?Q?ofpYenlNmvvRNEsSgxinXnE4pahJNtWTT=5F9sIkN?=
 =?us-ascii?Q?nvXb1Ar0Grqb-Zof71cODVUj8S8Af=5FtEekXUtAN?=
 =?us-ascii?Q?dtlQCZS06DXL59PrfbV7QRShMMDXGt5HsY5a8YM?=
 =?us-ascii?Q?Ot02ASZboL=5FI800J8yeYGrsrlsVfunLaQtgz20U?=
 =?us-ascii?Q?4spj7HZK1XKfZesP=5FuNKo65H301BEMoAFUWpvCt?=
 =?us-ascii?Q?8O5LS=5FMIbbIYzbN1rmwMP539oEezO8tS7tFO-VW?=
 =?us-ascii?Q?sxbta-NBJys3w8GexQbvFifeMX5eKtSCWyNzvKf?=
 =?us-ascii?Q?lGs15HMk3yukZUK0failBzmOoAZBcQLk0BkfLxn?=
 =?us-ascii?Q?QlhocA1rEnOMZPGh=5Fe0SxnnrGkuzBKMGcHwzoZQ?=
 =?us-ascii?Q?waV-0aD8zCuzunKJNTueVilUeJOZeVwRggEZmNa?=
 =?us-ascii?Q?7kWFX04omhFIZcfcYwX1SV4S9yS9nWYuqlR7TbE?=
 =?us-ascii?Q?vVAhhLOZgktDrKiw2fLAf6ab7VeHH2yq4BAIE5d?=
 =?us-ascii?Q?OOSSLhmU7zdPjw8b-dxaYERLYfkMOjm=5FqVh12bi?=
 =?us-ascii?Q?xPqYv6D3t8H17tD0CCAeoBMKSFJH1fZ4q9MdeVy?=
 =?us-ascii?Q?uWv=5FS2q=5FlQw=5F4xJ-FY3DrtxaJhyJSP-jOpFc1Qu?=
 =?us-ascii?Q?pQXeikVUtf0BgiEtLYAZHHXocbPELBt1uqJYsDO?=
 =?us-ascii?Q?0JbGvwfrWjjuVDVKsN4kbsh4G101lTLE46xfUeD?=
 =?us-ascii?Q?l-NM9FdGacna0PRNV9L55zOD=5FT0xAIbQWWutwov?=
 =?us-ascii?Q?-Pj=5Fm7YrTFHqrIqnWsnuxvxa1AvqO9UjigDWaqc?=
 =?us-ascii?Q?YcHvYfUrUykRRwXs-EaCj=5Ft=3E?=

--da95df9a243d6c650cddbbacc1be63885e2b4db53bad2a1b0c2f3db5f2e0
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=us-ascii
Mime-Version: 1.0

MEASLES - ISRAEL: (NORTH) NOSOCOMIAL
************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Thu 11 Jan 2024
Source: Jerusalem Post [edited]
<https://www.jpost.com/breaking-news/article-781813>


An unvaccinated child and another adult from the north contracted
measles, the Health Ministry reported on Thursday [11 Jan 2024]. So
far, 5 cases of measles have been uncovered in Israel's north in the
last month. Following an epidemiological investigation conducted in
the region, a link was found between the cases. The source of the
illness is a person who contracted measles abroad about a month ago
and stayed in the emergency room at Furia Hospital, Israeli media
added.

--
Communicated by:
ProMED

[This scenario occurs not infrequently. The rubeola virus is acquired
by an unvaccinated traveler from an area where measles circulates
commonly and then presents in a developed country where measles is
uncommon due to an aggressive vaccination program. It is often the
case, in my experience, that the index case is seen in a primary care
setting like an emergency room and is not promptly diagnosed and
isolated so secondary cases in individuals not vaccinated by choice or
too young to be vaccinated occur.

Additionally, originally the live attenuated measles vaccine, which
requires a cold chain, was even more heat unstable than now, and a
large outbreak of measles occurred in the 1980s in some individuals
who were likely immunized with vaccine that was improperly stored. In
addition to a formulation that was somewhat more heat stable, the
measles vaccine is now given as a 2-shot sequence instead of one.
Although some of the cases presented somewhat atypically, I personally
saw cases of classical measles with the high fever and descending rash
that were overtly misdiagnosed by others.

A relatively recent review of this potentially fatal preventable
disease can be found at:
Moss WJ. Measles. Lancet. 2017; 390: 2490-2502;
<https://pubmed.ncbi.nlm.nih.gov/28673424/>

Abstract
-------
"Measles is a highly contagious disease that results from infection
with measles virus and is still responsible for more than 100 000
deaths every year, down from more than 2 million deaths annually
before the introduction and widespread use of measles vaccine. Measles
virus is transmitted by the respiratory route and illness begins with
fever, cough, coryza, and conjunctivitis followed by a characteristic
rash. Complications of measles affect most organ systems, with
pneumonia accounting for most measles-associated morbidity and
mortality. The management of patients with measles includes provision
of vitamin A. Measles is best prevented through vaccination, and the
major reductions in measles incidence and mortality have renewed
interest in regional elimination and global eradication. However,
urgent efforts are needed to increase stagnating global coverage with
2 doses of measles vaccine through advocacy, education, and the
strengthening of routine immunisation systems. Use of combined
measles-rubella vaccines provides an opportunity to eliminate rubella
and congenital rubella syndrome. Ongoing research efforts, including
the development of point-of-care diagnostics and microneedle patches,
will facilitate progress towards measles elimination and
eradication."
- Mod.LL

ProMED map:
Israel: <https://promedmail.org/promed-post?place=3D8714196,90>]

[See Also:
Measles update (01): USA (PA) multiple potential exposure sites
http://promedmail.org/post/20240107.8714111
2023
----
Measles update (64): USA, Russia, Azerbaijan
http://promedmail.org/post/20231226.8713899
Measles update (31): Americas, Asia, Africa
http://promedmail.org/post/20230707.8711001
Measles update (30): W Pacific, Americas, E Mediterranean, Africa,
int'l travel http://promedmail.org/post/20230704.8710940
Measles update (29): E Mediterranean, Europe, Africa, Americas, int'l
travel http://promedmail.org/post/20230624.8710728
Measles update (28): Americas, E Mediterranean, W Pacific
http://promedmail.org/post/20230619.8710660
Measles update (21): global update
http://promedmail.org/post/20230428.8709755
Measles update (20): Europe, Asia, Africa, W. Pacific, Americas,
Middle East http://promedmail.org/post/20230423.8709653]
.................................................ll/rd/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3DlGamh_AKRkAnnihRYjjr9AYX77sBnWGylWRcwN318kNoMDAwdTAwMBTBh1x=
URS7gY3IV7Ahr-5YfMc1iMlg0sCO3pmVsysi9a7Bf1XMoMkvnNGRLn_7OYSHM9enrCyjPCUNHR4=
-g1fjnwVTWqBEizL4raPeHby_qWUihMc6A55NA-cJeor6ITbsgCVWW2I175cJKklvwfMsxTMrOT=
lirn_zet_Mv-R5b02RNSLFssMjPGuKu0GrHbLVUty2c4ljnHpFI6Ok98zyYPEQhOWcnJhvN4X7k=
8uhz9v04p5hG032ry5tEwkf0xP2oOueMmOR42hV-BqW5q7RAzmgHlKVNBg0n5V1TliT1pDKjGlO=
QzvSLh9dJbg5tXxcHGYDdWdjPFKpeK9IbvWDQWMb4pJFwesVeL0efIPMmaBIoNaIei49mLs8avh=
4pRRtH3-yPkDCcUV-a3cr0uDwIwJObQABqKUOKJG0WIthtoLMootzolkajL3ppRJ9xCpe_cov_f=
tfOhj-0xNYJFN1wQiweQhoEVj9Q1qtsVyrFqSTHM-aeR4qOG-UEKv5AQ7Jk3pTM-25A2o8oF5gX=
cSYH5ssSekyBaiIgZN2K8qBVT0rikIro2uRWterJgrjlh95JR4VaDRhKqh65so9It1dJJHK8fCE=
OCoqPODzEfGTCA0pAPSaWu8KRBMt1WVpcJMUYE2IXXsURcMPtF9do8A4c390zl_ZhWPYDM94EbG=
l7RCXzpPQJTQuZyfevSlBZE0DxD2mw5tbefAs-dBlEkM9P_8xLrdRD0miGsfxjpPwZWjyqNazEd=
vLWDrYbldWPyT2MNBGeoZFgujIey4iDDDgiC53mojtqtkPc4WT9m8l2eJooIcuslLuNRvR7AGV_=
6bY3C4XQqNgQTlBcGL6sMZ8ehCp_JDPam-OMGDIsZHs4BiZXwTj5Dj2OryMGRDfoB9j9l_y-3fG=
bmcuK5Qe-ckpofoZas5zHHEGhmZrf3HMXajwRw7egkrYYuId8mpFXD5_xOjeY95Q5OUKjYL_IXQ=
3vSVOZaH1VmPQh_UBkDoK_ZzkxMs_5xUe-fwj_5OwVoJ7dpQwj3_-c34ttvUnkP__z7Y5O0Wkl2=
utfoKRmh6Kdg_qF2H7NMC6_R6si8cUiDoYGLjRBTEdEyBPhpF3jBQXZNhJSevtEtALxj4N1_j11=
2VydSPQ916MZrZRv9PCdeNpY-DP2i40FJydo8QPBLlg=3D )
############################################################
############################################################

--da95df9a243d6c650cddbbacc1be63885e2b4db53bad2a1b0c2f3db5f2e0
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=us-ascii
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>MEASLES - ISRAEL: (NORTH) NOSOCOMIAL<br>*****************************=
*******<br>A ProMED-mail post<br><a href=3D"https://u19268662.ct.sendgrid.n=
et/ss/c/wscE2ng5fl6JrPIt48tisIijpefK5PNjW-mL-YZGnfgDOxU1G3gjwnPSi2Tfv3HA/42=
y/uRYZqis4RhOq7IQ_lN-otw/h0/sx1dXkE7JOF7CCp9NqchteyjdeGjZDOdd8LWEHV_wKE">ht=
tp://www.promedmail.org</a><br>ProMED-mail is a program of the<br>Internati=
onal Society for Infectious Diseases<br><a href=3D"https://u19268662.ct.sen=
dgrid.net/ss/c/wscE2ng5fl6JrPIt48tisCT5tpD4Upm3qyMCbcYSQvc/42y/uRYZqis4RhOq=
7IQ_lN-otw/h1/CbH51NE2Itt7WVUthh99jeR6xjY3l560npX2twfxVJc">http://www.isid.=
org</a><br><br>Date: Thu 11 Jan 2024=0D<br>Source: Jerusalem Post [edited]=0D=
<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/TLh_csrC34X_iXpbYoMam=
7vVCpr-z-EtOogyTbu4sqDvtORHJ2hxUqfNTZqIL-NQx5FuGc7Udx8NgumEfpsdew/42y/uRYZq=
is4RhOq7IQ_lN-otw/h2/wHlqxuHkZkzZdlvLXQC6Z3vTXlQ_73AoyYdvtoJ7Vbs">https://w=
ww.jpost.com/breaking-news/article-781813</a>=0D<br>=0D<br>=0D<br>An unvacc=
inated child and another adult from the north contracted<br>measles, the He=
alth Ministry reported on Thursday [11 Jan 2024]. So<br>far, 5 cases of mea=
sles have been uncovered in Israel's north in the<br>last month. Following =
an epidemiological investigation conducted in<br>the region, a link was fou=
nd between the cases. The source of the<br>illness is a person who contract=
ed measles abroad about a month ago<br>and stayed in the emergency room at =
Furia Hospital, Israeli media<br>added.=0D<br>=0D<br>--=0D<br>Communicated =
by:=0D<br>ProMED<br><br>[This scenario occurs not infrequently. The rubeola=
 virus is acquired<br>by an unvaccinated traveler from an area where measle=
s circulates<br>commonly and then presents in a developed country where mea=
sles is<br>uncommon due to an aggressive vaccination program. It is often t=
he<br>case, in my experience, that the index case is seen in a primary care=
<br>setting like an emergency room and is not promptly diagnosed and<br>iso=
lated so secondary cases in individuals not vaccinated by choice or<br>too =
young to be vaccinated occur.=0D<br>=0D<br>Additionally, originally the liv=
e attenuated measles vaccine, which<br>requires a cold chain, was even more=
 heat unstable than now, and a<br>large outbreak of measles occurred in the=
 1980s in some individuals<br>who were likely immunized with vaccine that w=
as improperly stored. In<br>addition to a formulation that was somewhat mor=
e heat stable, the<br>measles vaccine is now given as a 2-shot sequence ins=
tead of one.<br>Although some of the cases presented somewhat atypically, I=
 personally<br>saw cases of classical measles with the high fever and desce=
nding rash<br>that were overtly misdiagnosed by others.=0D<br>=0D<br>A rela=
tively recent review of this potentially fatal preventable<br>disease can b=
e found at:=0D<br>Moss WJ. Measles. Lancet. 2017; 390: 2490-2502;<br><a hre=
f=3D"https://u19268662.ct.sendgrid.net/ss/c/0oc7vsq5mmLjPwOs4PjMh3uPKFO3Rpo=
M8Ok2goq-HWwflt1WI0TeagK3xDwzx59IPpV6g9LV-adepn_gD1CMzA/42y/uRYZqis4RhOq7IQ=
_lN-otw/h3/3SvJrurbW0YYXKzUg_fi7UpXIbZbt9ozTpwCf1Opu7s">https://pubmed.ncbi=
.nlm.nih.gov/28673424/</a>=0D<br>=0D<br>Abstract=0D<br>-------=0D<br>"Measl=
es is a highly contagious disease that results from infection<br>with measl=
es virus and is still responsible for more than 100 000<br>deaths every yea=
r, down from more than 2 million deaths annually<br>before the introduction=
 and widespread use of measles vaccine. Measles<br>virus is transmitted by =
the respiratory route and illness begins with<br>fever, cough, coryza, and =
conjunctivitis followed by a characteristic<br>rash. Complications of measl=
es affect most organ systems, with<br>pneumonia accounting for most measles=
-associated morbidity and<br>mortality. The management of patients with mea=
sles includes provision<br>of vitamin A. Measles is best prevented through =
vaccination, and the<br>major reductions in measles incidence and mortality=
 have renewed<br>interest in regional elimination and global eradication. H=
owever,<br>urgent efforts are needed to increase stagnating global coverage=
 with<br>2 doses of measles vaccine through advocacy, education, and the<br=
>strengthening of routine immunisation systems. Use of combined<br>measles-=
rubella vaccines provides an opportunity to eliminate rubella<br>and congen=
ital rubella syndrome. Ongoing research efforts, including<br>the developme=
nt of point-of-care diagnostics and microneedle patches,<br>will facilitate=
 progress towards measles elimination and<br>eradication."=0D<br>- Mod.LL<b=
r><br>ProMED map:<br>Israel: <a href=3D"https://u19268662.ct.sendgrid.net/s=
s/c/sSnCkKCWBvais3EuVAOvgy2WOIX7pp1nXnn4AbwuQ3Z6WbkfhqXYXU-aTMPJ8yThv0PJ5gv=
L_x71aYFh-OhVmQ/42y/uRYZqis4RhOq7IQ_lN-otw/h4/76wmFdP6UBd3S81eniFybsd-_VjIf=
bPn0nfwgBEXrVs">https://promedmail.org/promed-post?place=3D8714196,90</a>]<=
br><br>[See Also:<br>Measles update (01): USA (PA) multiple potential expos=
ure sites<br>http://promedmail.org/post/20240107.8714111=0D<br>2023=0D<br>-=
---=0D<br>Measles update (64): USA, Russia, Azerbaijan<br>http://promedmail=
.org/post/20231226.8713899=0D<br>Measles update (31): Americas, Asia, Afric=
a<br>http://promedmail.org/post/20230707.8711001=0D<br>Measles update (30):=
 W Pacific, Americas, E Mediterranean, Africa,<br>int'l travel http://prome=
dmail.org/post/20230704.8710940=0D<br>Measles update (29): E Mediterranean,=
 Europe, Africa, Americas, int'l<br>travel http://promedmail.org/post/20230=
624.8710728=0D<br>Measles update (28): Americas, E Mediterranean, W Pacific=
<br>http://promedmail.org/post/20230619.8710660=0D<br>Measles update (21): =
global update<br>http://promedmail.org/post/20230428.8709755=0D<br>Measles =
update (20): Europe, Asia, Africa, W. Pacific, Americas,<br>Middle East htt=
p://promedmail.org/post/20230423.8709653]<br>..............................=
...................ll/rd/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3DlGamh_AKRkAnnihRYjjr9AYX77sBnWGylWRcwN318kNoMDAwdT=
AwMBTBh1xURS7gY3IV7Ahr-5YfMc1iMlg0sCO3pmVsysi9a7Bf1XMoMkvnNGRLn_7OYSHM9enrC=
yjPCUNHR4-g1fjnwVTWqBEizL4raPeHby_qWUihMc6A55NA-cJeor6ITbsgCVWW2I175cJKklvw=
fMsxTMrOTlirn_zet_Mv-R5b02RNSLFssMjPGuKu0GrHbLVUty2c4ljnHpFI6Ok98zyYPEQhOWc=
nJhvN4X7k8uhz9v04p5hG032ry5tEwkf0xP2oOueMmOR42hV-BqW5q7RAzmgHlKVNBg0n5V1Tli=
T1pDKjGlOQzvSLh9dJbg5tXxcHGYDdWdjPFKpeK9IbvWDQWMb4pJFwesVeL0efIPMmaBIoNaIei=
49mLs8avh4pRRtH3-yPkDCcUV-a3cr0uDwIwJObQABqKUOKJG0WIthtoLMootzolkajL3ppRJ9x=
Cpe_cov_ftfOhj-0xNYJFN1wQiweQhoEVj9Q1qtsVyrFqSTHM-aeR4qOG-UEKv5AQ7Jk3pTM-25=
A2o8oF5gXcSYH5ssSekyBaiIgZN2K8qBVT0rikIro2uRWterJgrjlh95JR4VaDRhKqh65so9It1=
dJJHK8fCEOCoqPODzEfGTCA0pAPSaWu8KRBMt1WVpcJMUYE2IXXsURcMPtF9do8A4c390zl_ZhW=
PYDM94EbGl7RCXzpPQJTQuZyfevSlBZE0DxD2mw5tbefAs-dBlEkM9P_8xLrdRD0miGsfxjpPwZ=
WjyqNazEdvLWDrYbldWPyT2MNBGeoZFgujIey4iDDDgiC53mojtqtkPc4WT9m8l2eJooIcuslLu=
NRvR7AGV_6bY3C4XQqNgQTlBcGL6sMZ8ehCp_JDPam-OMGDIsZHs4BiZXwTj5Dj2OryMGRDfoB9=
j9l_y-3fGbmcuK5Qe-ckpofoZas5zHHEGhmZrf3HMXajwRw7egkrYYuId8mpFXD5_xOjeY95Q5O=
UKjYL_IXQ3vSVOZaH1VmPQh_UBkDoK_ZzkxMs_5xUe-fwj_5OwVoJ7dpQwj3_-c34ttvUnkP__z=
7Y5O0Wkl2utfoKRmh6Kdg_qF2H7NMC6_R6si8cUiDoYGLjRBTEdEyBPhpF3jBQXZNhJSevtEtAL=
xj4N1_j112VydSPQ916MZrZRv9PCdeNpY-DP2i40FJydo8QPBLlg=3D" target=3D"_blank" =
class=3D"Unsubscribe--unsubscribePreferences" style=3D"font-family:sans-ser=
if;text-decoration:none;">Unsubscribe Preferences</a></div><br>############=
################################################<br>#######################=
#####################################<br><br><img src=3D"https://u19268662.=
ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/42y/uRYZqis4RhOq7IQ_lN-otw/ho.g=
if" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=3D"height:1px !imp=
ortant;width:1px !important;border-width:0 !important;margin-top:0 !importa=
nt;margin-bottom:0 !important;margin-right:0 !important;margin-left:0 !impo=
rtant;padding-top:0 !important;padding-bottom:0 !important;padding-right:0 =
!important;padding-left:0 !important;"/></body>
</html>
--da95df9a243d6c650cddbbacc1be63885e2b4db53bad2a1b0c2f3db5f2e0--
